R&D
🇺🇸 FDA Page 8FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Gain critical insights into global pharmaceutical R&D trends, drug discovery pipelines, and clinical trial advancements. Drive your pharma strategy.
Showing 85–96 of 117 articles
Abivax Stock Plummets Amid Safety Concerns in Ulcerative Colitis Trial
AbiVax falls as safety worries cloud ‘landmark’ immune drug results
Understanding Computer Software Assurance (CSA) and Its Benefits for Pharma
FDA Oncology Draft Guidance: Reducing Animal Testing for Cancer Drugs
Kardigan's IPO Plans: Fueling the Next Wave of Cardiovascular Drug Development
Top Biotech Penny Stocks to Watch in 2026: A Strategic Outlook
Biotech Movers: Moderna, Iovance, ALHC, and Summit Therapeutics in Focus
Eli Lilly's 340B Data Mandate: A New Tactic in Pharma's Discount Program Battle
Supreme Court Upholds Medicare Drug Price Negotiation: Implications for Pharma
Wave Life Sciences' Monthly Dosing Strategy for AATD: A Competitive Analysis
DCAT Week 2024: Strategic Imperatives for Pharma BD and Investors
Retro Biosciences Secures $1.8 Billion Valuation in Landmark Longevity Funding Round